510(k) Report

510(k) · Cleared

Cleared

Keratec Wound Dressings

K080949510(k) TraditionalCleared Feb 11, 2009314-day reviewClass U

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Keratec Limited · FRO Dressing, Wound, Drug

Cleared on Feb 11, 2009 as substantially equivalent to K061711 (Cook Biotech, Inc., 2006) and 3 other predicates after a 314-day review. Its family tree reaches back 4 generations to 1988. 3 later devices descend from it.

Decided
Feb 11, 2009
Review
314 days
Class
Class U
Product code
FRO
Recalls
None
Predicates
4

Its longest line of descent runs back 4 generations to K881854 (1988). 15 ancestors in all. 3 later devices descend from it, 2 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2006: 1 other ancestor2002: 2 other ancestors2001: 1 other ancestor1999: 1 other ancestor1998: 1 other ancestor1997: 1 other ancestor1993: 2 other ancestors1989: 1 other ancestor1991: 1 other ancestor2019: 1 descendant cleared2017: 1 descendant cleared2020: 1 descendant clearedK881854 · Sorbsan Topical Wound Dressing · E.G. Dick & Assoc. · 1988K982597 · Fibrcol Plus Collagen Wound Dressing with Alginate · Johnson & Johnson Medical, Inc. · 1998K014129 · Promogran Matrix Wound Dressing · Johnson & Johnson Medical, Ltd. · 2002K033523 · Collagen-Orc Antimicrobial Matrix · Johnson & Johnson Medical, Ltd. · 20041990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 3 other ancestors2 generations back: 3 other ancestors3 generations back: 3 other ancestors4 generations back: 2 other ancestors 1 generation forward: 2 descendants2 generations forward: 1 descendant K033523 · Collagen-Orc Antimicrobial Matrix · Johnson & Johnson Medical, Ltd. · 2004K014129 · Promogran Matrix Wound Dressing · Johnson & Johnson Medical, Ltd. · 2002K982597 · Fibrcol Plus Collagen Wound Dressing with Alginate · Johnson & Johnson Medical, Inc. · 1998K881854 · Sorbsan Topical Wound Dressing · E.G. Dick & Assoc. · 19880
  1. Root · 4 generations backK881854 Sorbsan Topical Wound DressingE.G. Dick & Assoc. · 1988
  2. 3 generations backK982597 Fibrcol Plus Collagen Wound Dressing with AlginateJohnson & Johnson Medical, Inc. · 1998
  3. 2 generations backK014129 Promogran Matrix Wound DressingJohnson & Johnson Medical, Ltd. · 2002
  4. 1 generation backK033523 Collagen-Orc Antimicrobial MatrixJohnson & Johnson Medical, Ltd. · 2004
  5. This deviceK080949 Keratec Wound DressingsKeratec Limited · 2009
  6. Descendant · cites it directly · 1 of its ownK162759 KeraStat (R) GelKeranetics, LLC · 2017
  7. Descendant · 2 generations on · 0 of its ownK192386 KeraStat CreamKeranetics · 2020
  8. Descendant · cites it directly · 0 of its ownK182010 ProgenaMatrixCell Constructs I, LLC · 2019 · Recalled

Most influential descendants

Showing 3 of 3 · See all
  • K162759KeraStat (R) GelKeranetics, LLC · 2017 · cites it directly1descendant
  • K192386KeraStat CreamKeranetics · 2020 · 2 generations on0descendants
  • K182010ProgenaMatrixCell Constructs I, LLC · 2019 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K881854Sorbsan Topical Wound DressingE.G. Dick & Assoc.1988—
−3K982597Fibrcol Plus Collagen Wound Dressing with AlginateJohnson & Johnson Medical, Inc.1998—
−2K014129Promogran Matrix Wound DressingJohnson & Johnson Medical, Ltd.2002—
−1K033523Collagen-Orc Antimicrobial MatrixJohnson & Johnson Medical, Ltd.2004—
0 (this device)K080949Keratec Wound DressingsKeratec Limited2009—
+1K162759KeraStat (R) GelKeranetics, LLC2017—
+2K192386KeraStat CreamKeranetics2020—
+1K182010ProgenaMatrixCell Constructs I, LLC20191

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198910
199110
199320
199710
199810
199910
200110
200220
200610

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201710
201910
202010
FIG. 1 — Lineage of K080949, 1988–2020Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FRO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FRO device

  1. #1 K261023 Microdacyn Wound Irrigation Solutionscore 15.5 · 14 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (4)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K061711Oasis Wound Matrix
Summary page 1
…on/Usual Name: Wound Dressings Classification Name: Wound and Burn Dressings 3. PREDICATE DEVICES * Oasis Wound Matrix by Healthpoint (K06171 1) * Biocore Medical Technologies inc. MediFil Collatek Hydrogel (K022995) *Biocore Medical Technologies Collatek Foa…
Cook Biotech, Inc.2006—
*K022995Collatek Hydrogel
Summary page 1
…and Burn Dressings 3. PREDICATE DEVICES * Oasis Wound Matrix by Healthpoint (K06171 1) * Biocore Medical Technologies inc. MediFil Collatek Hydrogel (K022995) *Biocore Medical Technologies Collatek Foamn (KO 12997) * Johnson & Johnson Collagen ORC Antimicrobial Matrix (K03…
Biocore Medical Technologies, Inc.2002—
*K012997Collatek FoamBiocore Medical Technologies, Inc.2001—
*K033523Collagen-Orc Antimicrobial Matrix
Summary page 1
…ies inc. MediFil Collatek Hydrogel (K022995) *Biocore Medical Technologies Collatek Foamn (KO 12997) * Johnson & Johnson Collagen ORC Antimicrobial Matrix (K033523) 4. DEVICE DESCRIPTION The Keratec Keragel, Kerafoam and Keraderm Wound Dressings (Keratec Wound Dressings) are de…
Johnson & Johnson Medical, Ltd.2004—

Also cleared against K061711: 15 other devices →

What descends from it? (3)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K162759KeraStat (R) GelKeranetics, LLC20171
K182010ProgenaMatrixCell Constructs I, LLC20190

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 21 years and passes through 4 companies; a new generation was cleared every 4.3 years on median.
  • None of the 15 ancestors has a recall.
  • Of its descendants, K162759 (Keranetics, LLC, 2017) has gone furthest, with 1 descendant of its own.
  • 15 other devices also cite its predicate K061711.

How does its category compare?

All FRO devices

FRO Dressing, Wound, Drug: FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.

FDA decisions per year · FRO

11in 2025

2007: 292008: 262009: 312010: 312011: 272012: 242013: 192014: 222015: 282016: 282017: 232018: 202019: 162020: 122021: 82022: 92023: 182024: 242025: 112026 (partial year): 17
2007high 31 (2009) · low 8 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FRO

176in 2025

2007: 187 days median2008: 130 days median2009: 136 days median2010: 146 days median2011: 177 days median2012: 96 days median2013: 194 days median2014: 214 days median2015: 249 days median2016: 222 days median2017: 147 days median2018: 206 days median2019: 270 days median2020: 226 days median2021: 275 days median2022: 332 days median2023: 283 days median2024: 263 days median2025: 176 days median2026 (partial year): 254 days median
2007high 332 (2022) · low 96 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FRO

2in 2024

2007: 42008: 12009: 12011: 42013: 12014: 12015: 22016: 32017: 12019: 12021: 62022: 22023: 2, 2 Class I2024: 22026 (partial year): 2
2007high 6 (2021) · low 0 (2010)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · FRO

192in 2025

2007: 552008: 302009: 452010: 1222011: 422012: 652013: 1392014: 2692015: 2972016: 1472017: 1492018: 1282019: 1362020: 1392021: 1832022: 1762023: 1982024: 2322025: 192
2007high 297 (2015) · low 30 (2008)2025

MAUDE reports naming product code FRO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200729187455
200826130130
200931136145
2010311460122
201127177442
20122496065
2013191941139
2014222141269
2015282492297
2016282223147
2017231471149
2018202060128
2019162701136
2020122260139
202182756183
202293322176
2023182832 (2)198
2024242632232
2025111760192
2026172542—

What is it indicated for?

The Keratec Keragel, Kerafoam and Keraderm Wound Dressings are intended for the management of partial and full thickness wounds such as: · first and second degree burns * severe sunburns * superficial injuries, cuts, abrasions and surgical wounds The Keratec Wound Dressings may also be used under guidance of a health care professional in the management of the following types of dry, light and moderately exudating partial and full thickness wounds: *…

Read the full statement (134 words)

The Keratec Keragel, Kerafoam and Keraderm Wound Dressings are intended

for the management of partial and full thickness wounds such as:

· first and second degree burns

* severe sunburns

* superficial injuries, cuts, abrasions and surgical wounds

The Keratec Wound Dressings may also be used under guidance of a health

care professional in the management of the following types of dry, light and

moderately exudating partial and full thickness wounds:

* Pressure (stage I-IV) and venous stasis ulcers

· Ulcers caused by mixed vascular etiologies

· Diabetic ulcers

* Donor sites and grafts

Keragel is intended for dry to moderately exuding wounds, Keraderm for low to

highly exuding wounds and Kerafoam for moderately exuding wounds to highly

exuding wounds.

The Keratec Wound Dressings are not intended to be used on third degree

burns.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K080949: Keratec Wound Dressings.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K080949

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026